ATP6AP2 and metabolic dysfunction-associated steatotic liver disease: To determine whether the PRR regulates hepatic lipid metabolism and plays a role in reversing or attenuating the development of hepatic steatosis, we used the PRR antagonist, PRO20, to block PRR activation in an HFD-induced mouse model of NAFLD after 2 weeks of HFD.